In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Scientists Give Leadership High Marks; Some Worry About Industry Influence

This article is powered by The Rose Sheet

Executive Summary

Union of Concerned Scientists' survey finds 65% of 354 respondents feel their direct supervisors back them on politically contentious positions; Commissioner Gottlieb gets glowing reviews.


Related Content

US FDA Hiring For Senior Staff Vacancies Boosted By Cures Act, Pilot Program – Gottlieb
FDA's Hiring Advantage: Scores In Best Places To Work Survey Continue To Rise
US FDA Taps Pfizer Executive For CDER Deputy Director Slot
Woodcock's 'Bias' In Sarepta Case Made Jenkins Worry About Future Drug Reviews
Merck R&D Exec Jumps To US FDA As Office Of New Drugs Deputy Director
Sequester Travel: Halved FDA Budget Limits Opportunities For Scientists, Impacts Senior Officials Too
FDA Pushes For Scientific Integrity As Staff Criticize Corporate Influence In External Survey
FDA Scientists Fear Retaliation For Conveying Health Risks, Survey Finds


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts